These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 24604886)
1. Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes. Zhang X; McGeoch SC; Megson IL; MacRury SM; Johnstone AM; Abraham P; Pearson DW; de Roos B; Holtrop G; O'Kennedy N; Lobley GE Mol Nutr Food Res; 2014 Jun; 58(6):1322-32. PubMed ID: 24604886 [TBL] [Abstract][Full Text] [Related]
2. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. Zhang X; McGeoch SC; Johnstone AM; Holtrop G; Sneddon AA; MacRury SM; Megson IL; Pearson DW; Abraham P; De Roos B; Lobley GE; O'Kennedy N J Thromb Thrombolysis; 2014 May; 37(4):455-63. PubMed ID: 24097206 [TBL] [Abstract][Full Text] [Related]
3. A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes. McGeoch SC; Johnstone AM; Lobley GE; Adamson J; Hickson K; Holtrop G; Fyfe C; Clark LF; Pearson DW; Abraham P; Megson IL; MacRury SM Diabet Med; 2013 Nov; 30(11):1314-23. PubMed ID: 23668675 [TBL] [Abstract][Full Text] [Related]
14. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610 [TBL] [Abstract][Full Text] [Related]
15. Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus. Spectre G; Mobarrez F; Stålesen R; Östenson CG; Varon D; Wallen H; Hjemdahl P Platelets; 2019; 30(3):348-355. PubMed ID: 29547014 [TBL] [Abstract][Full Text] [Related]
16. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584 [TBL] [Abstract][Full Text] [Related]
17. Platelet activity and hypercoagulation in type 2 diabetes. Pretorius L; Thomson GJA; Adams RCM; Nell TA; Laubscher WA; Pretorius E Cardiovasc Diabetol; 2018 Nov; 17(1):141. PubMed ID: 30388964 [TBL] [Abstract][Full Text] [Related]
18. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. Christersson C; Thulin Å; Siegbahn A Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820 [TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticles during and after acute coronary syndrome. Skeppholm M; Mobarrez F; Malmqvist K; Wallén H Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053 [TBL] [Abstract][Full Text] [Related]
20. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Tan KT; Tayebjee MH; Lim HS; Lip GY Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]